nodes	percent_of_prediction	percent_of_DWPC	metapath
Levobunolol—Cerebral ischaemia—Donepezil—Alzheimer's disease	0.0279	0.0317	CcSEcCtD
Levobunolol—Block heart—Donepezil—Alzheimer's disease	0.0238	0.027	CcSEcCtD
Levobunolol—Block heart—Memantine—Alzheimer's disease	0.0216	0.0245	CcSEcCtD
Levobunolol—Atrioventricular block—Galantamine—Alzheimer's disease	0.0179	0.0204	CcSEcCtD
Levobunolol—Stinging—Rivastigmine—Alzheimer's disease	0.0148	0.0168	CcSEcCtD
Levobunolol—Atrioventricular block—Donepezil—Alzheimer's disease	0.0139	0.0158	CcSEcCtD
Levobunolol—Lethargy—Galantamine—Alzheimer's disease	0.0129	0.0147	CcSEcCtD
Levobunolol—Cerebrovascular accident—Galantamine—Alzheimer's disease	0.0129	0.0147	CcSEcCtD
Levobunolol—Atrioventricular block—Memantine—Alzheimer's disease	0.0126	0.0144	CcSEcCtD
Levobunolol—Respiratory failure—Memantine—Alzheimer's disease	0.0125	0.0142	CcSEcCtD
Levobunolol—Atrioventricular block—Rivastigmine—Alzheimer's disease	0.0123	0.014	CcSEcCtD
Levobunolol—Respiratory failure—Rivastigmine—Alzheimer's disease	0.0122	0.0139	CcSEcCtD
Levobunolol—Ataxia—Galantamine—Alzheimer's disease	0.0119	0.0135	CcSEcCtD
Levobunolol—Diabetes mellitus—Donepezil—Alzheimer's disease	0.0113	0.0128	CcSEcCtD
Levobunolol—Cardiac failure congestive—Donepezil—Alzheimer's disease	0.0108	0.0123	CcSEcCtD
Levobunolol—Diabetes mellitus—Memantine—Alzheimer's disease	0.0102	0.0116	CcSEcCtD
Levobunolol—Hypoglycaemia—Donepezil—Alzheimer's disease	0.01	0.0114	CcSEcCtD
Levobunolol—Diabetes mellitus—Rivastigmine—Alzheimer's disease	0.00999	0.0114	CcSEcCtD
Levobunolol—Cerebrovascular accident—Donepezil—Alzheimer's disease	0.00999	0.0114	CcSEcCtD
Levobunolol—Cardiac failure congestive—Memantine—Alzheimer's disease	0.0098	0.0112	CcSEcCtD
Levobunolol—Depression—Galantamine—Alzheimer's disease	0.0097	0.011	CcSEcCtD
Levobunolol—Ataxia—Donepezil—Alzheimer's disease	0.0092	0.0105	CcSEcCtD
Levobunolol—Hypoglycaemia—Memantine—Alzheimer's disease	0.0091	0.0104	CcSEcCtD
Levobunolol—Lethargy—Memantine—Alzheimer's disease	0.00907	0.0103	CcSEcCtD
Levobunolol—Cerebrovascular accident—Memantine—Alzheimer's disease	0.00907	0.0103	CcSEcCtD
Levobunolol—Hypoglycaemia—Rivastigmine—Alzheimer's disease	0.00891	0.0101	CcSEcCtD
Levobunolol—Bradycardia—Galantamine—Alzheimer's disease	0.00889	0.0101	CcSEcCtD
Levobunolol—Diplopia—Memantine—Alzheimer's disease	0.00889	0.0101	CcSEcCtD
Levobunolol—Cerebrovascular accident—Rivastigmine—Alzheimer's disease	0.00887	0.0101	CcSEcCtD
Levobunolol—Diplopia—Rivastigmine—Alzheimer's disease	0.00869	0.00989	CcSEcCtD
Levobunolol—Cardiac arrest—Memantine—Alzheimer's disease	0.00845	0.00962	CcSEcCtD
Levobunolol—Visual impairment—Galantamine—Alzheimer's disease	0.00842	0.00958	CcSEcCtD
Levobunolol—Ataxia—Memantine—Alzheimer's disease	0.00835	0.00951	CcSEcCtD
Levobunolol—Cardiac arrest—Rivastigmine—Alzheimer's disease	0.00827	0.00941	CcSEcCtD
Levobunolol—Ataxia—Rivastigmine—Alzheimer's disease	0.00817	0.0093	CcSEcCtD
Levobunolol—Arrhythmia—Galantamine—Alzheimer's disease	0.0078	0.00888	CcSEcCtD
Levobunolol—Bronchospasm—Memantine—Alzheimer's disease	0.00755	0.0086	CcSEcCtD
Levobunolol—Depression—Donepezil—Alzheimer's disease	0.00752	0.00856	CcSEcCtD
Levobunolol—Bronchospasm—Rivastigmine—Alzheimer's disease	0.00739	0.00841	CcSEcCtD
Levobunolol—Conjunctivitis—Donepezil—Alzheimer's disease	0.00733	0.00834	CcSEcCtD
Levobunolol—Erectile dysfunction—Memantine—Alzheimer's disease	0.00707	0.00805	CcSEcCtD
Levobunolol—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.00692	0.00787	CcSEcCtD
Levobunolol—Bradycardia—Donepezil—Alzheimer's disease	0.00689	0.00784	CcSEcCtD
Levobunolol—Depression—Memantine—Alzheimer's disease	0.00683	0.00777	CcSEcCtD
Levobunolol—Syncope—Galantamine—Alzheimer's disease	0.00682	0.00776	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Memantine—Alzheimer's disease	0.00679	0.00773	CcSEcCtD
Levobunolol—Palpitations—Galantamine—Alzheimer's disease	0.00672	0.00765	CcSEcCtD
Levobunolol—Loss of consciousness—Galantamine—Alzheimer's disease	0.00668	0.00761	CcSEcCtD
Levobunolol—Depression—Rivastigmine—Alzheimer's disease	0.00668	0.0076	CcSEcCtD
Levobunolol—Conjunctivitis—Memantine—Alzheimer's disease	0.00666	0.00757	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.00664	0.00756	CcSEcCtD
Levobunolol—Visual impairment—Donepezil—Alzheimer's disease	0.00652	0.00742	CcSEcCtD
Levobunolol—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.00651	0.00741	CcSEcCtD
Levobunolol—Chest pain—Galantamine—Alzheimer's disease	0.00647	0.00737	CcSEcCtD
Levobunolol—Confusional state—Galantamine—Alzheimer's disease	0.00626	0.00712	CcSEcCtD
Levobunolol—Bradycardia—Memantine—Alzheimer's disease	0.00626	0.00712	CcSEcCtD
Levobunolol—Bradycardia—Rivastigmine—Alzheimer's disease	0.00612	0.00697	CcSEcCtD
Levobunolol—Shock—Galantamine—Alzheimer's disease	0.00611	0.00695	CcSEcCtD
Levobunolol—Arrhythmia—Donepezil—Alzheimer's disease	0.00605	0.00688	CcSEcCtD
Levobunolol—Alopecia—Donepezil—Alzheimer's disease	0.00598	0.00681	CcSEcCtD
Levobunolol—Visual impairment—Memantine—Alzheimer's disease	0.00592	0.00674	CcSEcCtD
Levobunolol—Erythema multiforme—Memantine—Alzheimer's disease	0.00581	0.00661	CcSEcCtD
Levobunolol—Hypotension—Galantamine—Alzheimer's disease	0.0058	0.0066	CcSEcCtD
Levobunolol—Visual impairment—Rivastigmine—Alzheimer's disease	0.0058	0.00659	CcSEcCtD
Levobunolol—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.00569	0.00647	CcSEcCtD
Levobunolol—Paraesthesia—Galantamine—Alzheimer's disease	0.00557	0.00634	CcSEcCtD
Levobunolol—Arrhythmia—Memantine—Alzheimer's disease	0.00549	0.00625	CcSEcCtD
Levobunolol—Alopecia—Memantine—Alzheimer's disease	0.00543	0.00618	CcSEcCtD
Levobunolol—Arrhythmia—Rivastigmine—Alzheimer's disease	0.00537	0.00611	CcSEcCtD
Levobunolol—Alopecia—Rivastigmine—Alzheimer's disease	0.00531	0.00605	CcSEcCtD
Levobunolol—Syncope—Donepezil—Alzheimer's disease	0.00529	0.00601	CcSEcCtD
Levobunolol—Loss of consciousness—Donepezil—Alzheimer's disease	0.00518	0.00589	CcSEcCtD
Levobunolol—Feeling abnormal—Galantamine—Alzheimer's disease	0.00511	0.00582	CcSEcCtD
Levobunolol—Chest pain—Donepezil—Alzheimer's disease	0.00502	0.00571	CcSEcCtD
Levobunolol—Confusional state—Donepezil—Alzheimer's disease	0.00485	0.00552	CcSEcCtD
Levobunolol—Syncope—Memantine—Alzheimer's disease	0.0048	0.00546	CcSEcCtD
Levobunolol—Timolol—CYP2D6—Alzheimer's disease	0.00477	0.376	CrCbGaD
Levobunolol—Shock—Donepezil—Alzheimer's disease	0.00473	0.00539	CcSEcCtD
Levobunolol—Palpitations—Memantine—Alzheimer's disease	0.00473	0.00538	CcSEcCtD
Levobunolol—Loss of consciousness—Memantine—Alzheimer's disease	0.0047	0.00535	CcSEcCtD
Levobunolol—Syncope—Rivastigmine—Alzheimer's disease	0.00469	0.00534	CcSEcCtD
Levobunolol—Palpitations—Rivastigmine—Alzheimer's disease	0.00463	0.00526	CcSEcCtD
Levobunolol—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.0046	0.00524	CcSEcCtD
Levobunolol—Hypersensitivity—Galantamine—Alzheimer's disease	0.00457	0.0052	CcSEcCtD
Levobunolol—Chest pain—Memantine—Alzheimer's disease	0.00456	0.00518	CcSEcCtD
Levobunolol—Hypotension—Donepezil—Alzheimer's disease	0.00449	0.00511	CcSEcCtD
Levobunolol—Chest pain—Rivastigmine—Alzheimer's disease	0.00446	0.00507	CcSEcCtD
Levobunolol—Asthenia—Galantamine—Alzheimer's disease	0.00445	0.00507	CcSEcCtD
Levobunolol—Confusional state—Memantine—Alzheimer's disease	0.0044	0.00501	CcSEcCtD
Levobunolol—Paraesthesia—Donepezil—Alzheimer's disease	0.00432	0.00492	CcSEcCtD
Levobunolol—Confusional state—Rivastigmine—Alzheimer's disease	0.00431	0.0049	CcSEcCtD
Levobunolol—Shock—Memantine—Alzheimer's disease	0.0043	0.00489	CcSEcCtD
Levobunolol—Dyspnoea—Donepezil—Alzheimer's disease	0.00429	0.00488	CcSEcCtD
Levobunolol—Carteolol—CYP2D6—Alzheimer's disease	0.00425	0.335	CrCbGaD
Levobunolol—Diarrhoea—Galantamine—Alzheimer's disease	0.00425	0.00483	CcSEcCtD
Levobunolol—Shock—Rivastigmine—Alzheimer's disease	0.0042	0.00478	CcSEcCtD
Levobunolol—Pain—Donepezil—Alzheimer's disease	0.00411	0.00468	CcSEcCtD
Levobunolol—Dizziness—Galantamine—Alzheimer's disease	0.0041	0.00467	CcSEcCtD
Levobunolol—Hypotension—Memantine—Alzheimer's disease	0.00408	0.00464	CcSEcCtD
Levobunolol—Hypotension—Rivastigmine—Alzheimer's disease	0.00399	0.00454	CcSEcCtD
Levobunolol—Feeling abnormal—Donepezil—Alzheimer's disease	0.00396	0.00451	CcSEcCtD
Levobunolol—Paraesthesia—Memantine—Alzheimer's disease	0.00392	0.00446	CcSEcCtD
Levobunolol—Dyspnoea—Memantine—Alzheimer's disease	0.00389	0.00443	CcSEcCtD
Levobunolol—Headache—Galantamine—Alzheimer's disease	0.00389	0.00442	CcSEcCtD
Levobunolol—Paraesthesia—Rivastigmine—Alzheimer's disease	0.00384	0.00437	CcSEcCtD
Levobunolol—Urticaria—Donepezil—Alzheimer's disease	0.00382	0.00435	CcSEcCtD
Levobunolol—Dyspnoea—Rivastigmine—Alzheimer's disease	0.00381	0.00433	CcSEcCtD
Levobunolol—Pain—Memantine—Alzheimer's disease	0.00373	0.00425	CcSEcCtD
Levobunolol—Nausea—Galantamine—Alzheimer's disease	0.00369	0.0042	CcSEcCtD
Levobunolol—Pain—Rivastigmine—Alzheimer's disease	0.00365	0.00416	CcSEcCtD
Levobunolol—Feeling abnormal—Memantine—Alzheimer's disease	0.0036	0.0041	CcSEcCtD
Levobunolol—Hypersensitivity—Donepezil—Alzheimer's disease	0.00354	0.00403	CcSEcCtD
Levobunolol—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.00352	0.00401	CcSEcCtD
Levobunolol—Urticaria—Memantine—Alzheimer's disease	0.00347	0.00395	CcSEcCtD
Levobunolol—Asthenia—Donepezil—Alzheimer's disease	0.00345	0.00393	CcSEcCtD
Levobunolol—Pruritus—Donepezil—Alzheimer's disease	0.0034	0.00387	CcSEcCtD
Levobunolol—Urticaria—Rivastigmine—Alzheimer's disease	0.00339	0.00386	CcSEcCtD
Levobunolol—Diarrhoea—Donepezil—Alzheimer's disease	0.00329	0.00375	CcSEcCtD
Levobunolol—Hypersensitivity—Memantine—Alzheimer's disease	0.00322	0.00366	CcSEcCtD
Levobunolol—Dizziness—Donepezil—Alzheimer's disease	0.00318	0.00362	CcSEcCtD
Levobunolol—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.00315	0.00358	CcSEcCtD
Levobunolol—Asthenia—Memantine—Alzheimer's disease	0.00313	0.00357	CcSEcCtD
Levobunolol—Pruritus—Memantine—Alzheimer's disease	0.00309	0.00352	CcSEcCtD
Levobunolol—Asthenia—Rivastigmine—Alzheimer's disease	0.00307	0.00349	CcSEcCtD
Levobunolol—Pruritus—Rivastigmine—Alzheimer's disease	0.00302	0.00344	CcSEcCtD
Levobunolol—Headache—Donepezil—Alzheimer's disease	0.00301	0.00343	CcSEcCtD
Levobunolol—Diarrhoea—Memantine—Alzheimer's disease	0.00299	0.0034	CcSEcCtD
Levobunolol—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00292	0.00333	CcSEcCtD
Levobunolol—Dizziness—Memantine—Alzheimer's disease	0.00289	0.00329	CcSEcCtD
Levobunolol—Nausea—Donepezil—Alzheimer's disease	0.00286	0.00325	CcSEcCtD
Levobunolol—Dizziness—Rivastigmine—Alzheimer's disease	0.00283	0.00322	CcSEcCtD
Levobunolol—Headache—Memantine—Alzheimer's disease	0.00274	0.00311	CcSEcCtD
Levobunolol—Headache—Rivastigmine—Alzheimer's disease	0.00268	0.00305	CcSEcCtD
Levobunolol—Nausea—Memantine—Alzheimer's disease	0.00259	0.00295	CcSEcCtD
Levobunolol—Nausea—Rivastigmine—Alzheimer's disease	0.00254	0.00289	CcSEcCtD
Levobunolol—Pindolol—CYP2D6—Alzheimer's disease	0.00238	0.188	CrCbGaD
Levobunolol—Propranolol—CYP2D6—Alzheimer's disease	0.0013	0.102	CrCbGaD
Levobunolol—ADRB2—G alpha (s) signalling events—CRH—Alzheimer's disease	0.000906	0.00835	CbGpPWpGaD
Levobunolol—ADRB2—Arf6 trafficking events—INS—Alzheimer's disease	0.000892	0.00821	CbGpPWpGaD
Levobunolol—ADRB1—G alpha (s) signalling events—NPS—Alzheimer's disease	0.000878	0.00809	CbGpPWpGaD
Levobunolol—ADRB2—G alpha (s) signalling events—NPS—Alzheimer's disease	0.000859	0.00791	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—PYY—Alzheimer's disease	0.000841	0.00774	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—PYY—Alzheimer's disease	0.000822	0.00757	CbGpPWpGaD
Levobunolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR6—Alzheimer's disease	0.000819	0.00754	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR6—Alzheimer's disease	0.000801	0.00738	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR6—Alzheimer's disease	0.000702	0.00646	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR6—Alzheimer's disease	0.000686	0.00632	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Other—CCR5—Alzheimer's disease	0.000676	0.00623	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Other—HTR2A—Alzheimer's disease	0.000662	0.0061	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—PYY—Alzheimer's disease	0.00064	0.0059	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—PYY—Alzheimer's disease	0.000626	0.00577	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—GAL—Alzheimer's disease	0.000583	0.00537	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—GAL—Alzheimer's disease	0.00057	0.00525	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—HTR6—Alzheimer's disease	0.000534	0.00492	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—HTR6—Alzheimer's disease	0.000523	0.00481	CbGpPWpGaD
Levobunolol—ADRB1—Calcium Regulation in the Cardiac Cell—PRKCG—Alzheimer's disease	0.000492	0.00453	CbGpPWpGaD
Levobunolol—ADRB2—Calcium Regulation in the Cardiac Cell—PRKCG—Alzheimer's disease	0.000481	0.00443	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—NPY—Alzheimer's disease	0.000458	0.00422	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—NPY—Alzheimer's disease	0.000448	0.00412	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—GAL—Alzheimer's disease	0.000444	0.00409	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—GAL—Alzheimer's disease	0.000434	0.004	CbGpPWpGaD
Levobunolol—ADRB1—Calcium Regulation in the Cardiac Cell—CALM1—Alzheimer's disease	0.000426	0.00392	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—NPS—Alzheimer's disease	0.000419	0.00386	CbGpPWpGaD
Levobunolol—ADRB2—Calcium Regulation in the Cardiac Cell—CALM1—Alzheimer's disease	0.000416	0.00383	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—NPS—Alzheimer's disease	0.00041	0.00377	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—SST—Alzheimer's disease	0.000399	0.00368	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—SST—Alzheimer's disease	0.000391	0.0036	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—APP—Alzheimer's disease	0.000389	0.00358	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—APP—Alzheimer's disease	0.000381	0.00351	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—PYY—Alzheimer's disease	0.000362	0.00333	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—PYY—Alzheimer's disease	0.000354	0.00326	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—NPY—Alzheimer's disease	0.000349	0.00321	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—IAPP—Alzheimer's disease	0.000346	0.00319	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—NPY—Alzheimer's disease	0.000341	0.00314	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—IAPP—Alzheimer's disease	0.000339	0.00312	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—CRH—Alzheimer's disease	0.000336	0.0031	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—CRH—Alzheimer's disease	0.000329	0.00303	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—PYY—Alzheimer's disease	0.000329	0.00303	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—PYY—Alzheimer's disease	0.000321	0.00296	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—NPS—Alzheimer's disease	0.000319	0.00294	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—NPS—Alzheimer's disease	0.000312	0.00287	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—SST—Alzheimer's disease	0.000304	0.0028	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—HTR6—Alzheimer's disease	0.000302	0.00278	CbGpPWpGaD
Levobunolol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR5—Alzheimer's disease	0.0003	0.00277	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—SST—Alzheimer's disease	0.000298	0.00274	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—APP—Alzheimer's disease	0.000296	0.00273	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—HTR6—Alzheimer's disease	0.000295	0.00272	CbGpPWpGaD
Levobunolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—Alzheimer's disease	0.000294	0.00271	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR5—Alzheimer's disease	0.000294	0.00271	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—APP—Alzheimer's disease	0.00029	0.00267	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—Alzheimer's disease	0.000288	0.00265	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—CDK5—Alzheimer's disease	0.000285	0.00262	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—CDK5—Alzheimer's disease	0.000279	0.00257	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—HTR6—Alzheimer's disease	0.000274	0.00253	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—HTR6—Alzheimer's disease	0.000268	0.00247	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	0.000257	0.00237	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	0.000252	0.00232	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	0.000252	0.00232	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—GAL—Alzheimer's disease	0.000251	0.00231	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	0.000246	0.00227	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—GAL—Alzheimer's disease	0.000245	0.00226	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—GAL—Alzheimer's disease	0.000228	0.0021	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—GAL—Alzheimer's disease	0.000223	0.00205	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—TTR—Alzheimer's disease	0.000222	0.00205	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	0.000221	0.00203	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—TTR—Alzheimer's disease	0.000217	0.002	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	0.000216	0.00199	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—NPY—Alzheimer's disease	0.000197	0.00181	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	0.000197	0.00181	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—CCR5—Alzheimer's disease	0.000196	0.00181	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—IAPP—Alzheimer's disease	0.000196	0.0018	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PYY—Alzheimer's disease	0.000194	0.00179	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—NPY—Alzheimer's disease	0.000193	0.00177	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	0.000193	0.00177	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—HTR2A—Alzheimer's disease	0.000192	0.00177	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—CCR5—Alzheimer's disease	0.000192	0.00177	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—IAPP—Alzheimer's disease	0.000192	0.00176	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—CRH—Alzheimer's disease	0.00019	0.00175	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PYY—Alzheimer's disease	0.00019	0.00175	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—HTR2A—Alzheimer's disease	0.000188	0.00173	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—CRH—Alzheimer's disease	0.000186	0.00171	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—NPS—Alzheimer's disease	0.00018	0.00166	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—NPY—Alzheimer's disease	0.000179	0.00165	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—IAPP—Alzheimer's disease	0.000178	0.00164	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—NPS—Alzheimer's disease	0.000176	0.00162	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—NPY—Alzheimer's disease	0.000175	0.00161	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—IAPP—Alzheimer's disease	0.000174	0.0016	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—CRH—Alzheimer's disease	0.000173	0.00159	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—SST—Alzheimer's disease	0.000172	0.00158	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—GAB2—Alzheimer's disease	0.000172	0.00158	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—CRH—Alzheimer's disease	0.000169	0.00155	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CDK5—Alzheimer's disease	0.000168	0.00155	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—F2—Alzheimer's disease	0.000168	0.00155	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—GAB2—Alzheimer's disease	0.000168	0.00155	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—SST—Alzheimer's disease	0.000168	0.00155	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—APP—Alzheimer's disease	0.000168	0.00154	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CDK5—Alzheimer's disease	0.000165	0.00152	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—F2—Alzheimer's disease	0.000165	0.00151	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—APP—Alzheimer's disease	0.000164	0.00151	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—NPS—Alzheimer's disease	0.000164	0.00151	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—PPP3CA—Alzheimer's disease	0.000163	0.0015	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—HTR6—Alzheimer's disease	0.000162	0.00149	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—NPS—Alzheimer's disease	0.00016	0.00147	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—PPP3CA—Alzheimer's disease	0.000159	0.00147	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—HTR6—Alzheimer's disease	0.000158	0.00146	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—PLCB1—Alzheimer's disease	0.000158	0.00146	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—GAB2—Alzheimer's disease	0.000156	0.00144	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—SST—Alzheimer's disease	0.000156	0.00144	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—PLCB1—Alzheimer's disease	0.000155	0.00142	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—GAB2—Alzheimer's disease	0.000153	0.00141	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—SST—Alzheimer's disease	0.000153	0.00141	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—APP—Alzheimer's disease	0.000152	0.0014	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—CCL2—Alzheimer's disease	0.00015	0.00138	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—APP—Alzheimer's disease	0.000149	0.00137	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PSENEN—Alzheimer's disease	0.000147	0.00135	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—CCL2—Alzheimer's disease	0.000147	0.00135	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—APH1A—Alzheimer's disease	0.000145	0.00134	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PSENEN—Alzheimer's disease	0.000144	0.00133	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—PLCB1—Alzheimer's disease	0.000144	0.00132	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—APH1A—Alzheimer's disease	0.000142	0.00131	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—NCSTN—Alzheimer's disease	0.000141	0.0013	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—PLCB1—Alzheimer's disease	0.00014	0.00129	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—NCSTN—Alzheimer's disease	0.000138	0.00127	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—LRP1—Alzheimer's disease	0.000138	0.00127	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—LRP1—Alzheimer's disease	0.000135	0.00124	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—GFAP—Alzheimer's disease	0.000135	0.00124	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—GAL—Alzheimer's disease	0.000135	0.00124	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—GFAP—Alzheimer's disease	0.000132	0.00121	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—GAL—Alzheimer's disease	0.000132	0.00121	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—A2M—Alzheimer's disease	0.000119	0.00109	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000117	0.00108	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—A2M—Alzheimer's disease	0.000116	0.00107	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PSEN2—Alzheimer's disease	0.000115	0.00106	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000114	0.00105	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PSEN2—Alzheimer's disease	0.000112	0.00103	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000111	0.00102	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000108	0.000998	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000108	0.000998	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000106	0.000978	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000106	0.000977	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—NPY—Alzheimer's disease	0.000106	0.000973	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—IAPP—Alzheimer's disease	0.000105	0.000967	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000104	0.000956	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—NPY—Alzheimer's disease	0.000103	0.000952	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—IAPP—Alzheimer's disease	0.000103	0.000946	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CRH—Alzheimer's disease	0.000102	0.000939	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—CCR5—Alzheimer's disease	0.000101	0.000926	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CRH—Alzheimer's disease	9.97e-05	0.000919	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—HTR2A—Alzheimer's disease	9.84e-05	0.000907	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—CCR5—Alzheimer's disease	9.84e-05	0.000906	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—NPS—Alzheimer's disease	9.67e-05	0.00089	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—HTR2A—Alzheimer's disease	9.63e-05	0.000887	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PPP3CA—Alzheimer's disease	9.62e-05	0.000886	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—F2—Alzheimer's disease	9.5e-05	0.000875	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PTK2B—Alzheimer's disease	9.48e-05	0.000873	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—NPS—Alzheimer's disease	9.46e-05	0.000871	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PPP3CA—Alzheimer's disease	9.41e-05	0.000866	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—F2—Alzheimer's disease	9.3e-05	0.000856	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PTK2B—Alzheimer's disease	9.27e-05	0.000854	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—NTRK2—Alzheimer's disease	9.22e-05	0.000849	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—GAB2—Alzheimer's disease	9.22e-05	0.000849	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—SST—Alzheimer's disease	9.22e-05	0.000849	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—CALM1—Alzheimer's disease	9.18e-05	0.000846	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—GSK3A—Alzheimer's disease	9.14e-05	0.000842	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—GAB2—Alzheimer's disease	9.02e-05	0.000831	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—SST—Alzheimer's disease	9.02e-05	0.000831	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—NTRK2—Alzheimer's disease	9.02e-05	0.000831	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—APP—Alzheimer's disease	8.99e-05	0.000828	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—CALM1—Alzheimer's disease	8.98e-05	0.000827	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—GSK3A—Alzheimer's disease	8.94e-05	0.000823	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—APP—Alzheimer's disease	8.79e-05	0.00081	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—F2—Alzheimer's disease	8.63e-05	0.000795	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PLCB1—Alzheimer's disease	8.48e-05	0.000781	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—F2—Alzheimer's disease	8.44e-05	0.000777	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PLCB1—Alzheimer's disease	8.29e-05	0.000764	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—NGFR—Alzheimer's disease	7.91e-05	0.000729	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—CREB1—Alzheimer's disease	7.86e-05	0.000724	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—NGFR—Alzheimer's disease	7.74e-05	0.000713	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—ADAM10—Alzheimer's disease	7.73e-05	0.000712	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—CCL2—Alzheimer's disease	7.69e-05	0.000708	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—CREB1—Alzheimer's disease	7.69e-05	0.000708	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—ADAM10—Alzheimer's disease	7.56e-05	0.000696	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—CCL2—Alzheimer's disease	7.52e-05	0.000693	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—S100B—Alzheimer's disease	7.31e-05	0.000673	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—S100B—Alzheimer's disease	7.15e-05	0.000658	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—IGF2—Alzheimer's disease	6.96e-05	0.000641	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—IGF2—Alzheimer's disease	6.81e-05	0.000627	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—IGF1R—Alzheimer's disease	6.73e-05	0.00062	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—IGF1R—Alzheimer's disease	6.58e-05	0.000606	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—LPL—Alzheimer's disease	6.45e-05	0.000594	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—MEF2C—Alzheimer's disease	6.39e-05	0.000589	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—LPL—Alzheimer's disease	6.31e-05	0.000581	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PRKCG—Alzheimer's disease	6.27e-05	0.000577	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—MEF2C—Alzheimer's disease	6.25e-05	0.000576	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PRKCG—Alzheimer's disease	6.13e-05	0.000565	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—NGF—Alzheimer's disease	6.11e-05	0.000563	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—NGF—Alzheimer's disease	5.98e-05	0.00055	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CCR5—Alzheimer's disease	5.94e-05	0.000547	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—HTR2A—Alzheimer's disease	5.82e-05	0.000536	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CCR5—Alzheimer's disease	5.81e-05	0.000535	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—HTR2A—Alzheimer's disease	5.69e-05	0.000524	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CALM1—Alzheimer's disease	5.43e-05	0.0005	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—LEP—Alzheimer's disease	5.41e-05	0.000498	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—APOE—Alzheimer's disease	5.41e-05	0.000498	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CAV1—Alzheimer's disease	5.36e-05	0.000493	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CALM1—Alzheimer's disease	5.31e-05	0.000489	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—LEP—Alzheimer's disease	5.29e-05	0.000487	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—APOE—Alzheimer's disease	5.29e-05	0.000487	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CAV1—Alzheimer's disease	5.24e-05	0.000483	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—ESR1—Alzheimer's disease	5.16e-05	0.000475	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—F2—Alzheimer's disease	5.1e-05	0.00047	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—ESR1—Alzheimer's disease	5.05e-05	0.000465	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—NOTCH1—Alzheimer's disease	4.99e-05	0.000459	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—F2—Alzheimer's disease	4.99e-05	0.000459	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—NOTCH1—Alzheimer's disease	4.88e-05	0.000449	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—GSK3B—Alzheimer's disease	4.68e-05	0.000431	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CREB1—Alzheimer's disease	4.64e-05	0.000428	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—INS—Alzheimer's disease	4.62e-05	0.000425	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—GSK3B—Alzheimer's disease	4.58e-05	0.000422	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CCL2—Alzheimer's disease	4.54e-05	0.000418	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CREB1—Alzheimer's disease	4.54e-05	0.000418	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—INS—Alzheimer's disease	4.52e-05	0.000416	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—IGF1—Alzheimer's disease	4.47e-05	0.000411	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CCL2—Alzheimer's disease	4.45e-05	0.000409	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—IGF1—Alzheimer's disease	4.37e-05	0.000402	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—NOS3—Alzheimer's disease	4.05e-05	0.000373	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—NOS3—Alzheimer's disease	3.96e-05	0.000365	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—AKT1—Alzheimer's disease	3.47e-05	0.00032	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CASP3—Alzheimer's disease	3.44e-05	0.000317	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—IL6—Alzheimer's disease	3.42e-05	0.000315	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—AKT1—Alzheimer's disease	3.39e-05	0.000313	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CASP3—Alzheimer's disease	3.36e-05	0.00031	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—IL6—Alzheimer's disease	3.34e-05	0.000308	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—MAPK8—Alzheimer's disease	3.16e-05	0.000291	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—AKT1—Alzheimer's disease	3.15e-05	0.00029	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—MAPK8—Alzheimer's disease	3.09e-05	0.000285	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—AKT1—Alzheimer's disease	3.08e-05	0.000284	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—VEGFA—Alzheimer's disease	2.92e-05	0.000269	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—VEGFA—Alzheimer's disease	2.85e-05	0.000263	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—TGFB1—Alzheimer's disease	2.68e-05	0.000247	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—TGFB1—Alzheimer's disease	2.62e-05	0.000241	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—TP53—Alzheimer's disease	2.2e-05	0.000203	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—TP53—Alzheimer's disease	2.16e-05	0.000199	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—IL6—Alzheimer's disease	2.02e-05	0.000186	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—IL6—Alzheimer's disease	1.97e-05	0.000182	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—AKT1—Alzheimer's disease	1.86e-05	0.000171	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—AKT1—Alzheimer's disease	1.82e-05	0.000168	CbGpPWpGaD
